
Ekobact 1000mg/500mg Injection
Marketer
Biotics Lab Life Services Private Limited
Salt Composition
Cefoperazone (1000mg) + Sulbactam (500mg)
Overview Ekobact 1000mg/500mg Injection
Bactrocomb 1000mg/500mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial growth and spread. Administered solely under medical supervision, consistent adherence to the prescribed dosage is crucial; prematurely ceasing treatment may compromise its effectiveness. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe reactions necessitate immediate medical attention. Allergic responses (e.g., rash, pruritus, edema, dyspnea) demand urgent medical help. Inform your physician about all current medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While typically non-impairing to driving, refrain from operating vehicles if experiencing drowsiness or dizziness. Adequate rest, a balanced diet, and hydration support recovery. Your doctor may order tests to monitor treatment efficacy.
Primary Ingredients of Ekobact 1000mg/500mg Injection
No text provided. Please provide the text you wish to be rewritten.
Uses of Ekobact 1000mg/500mg Injection
Managing Bacterial Infections
Major Benefits of Ekobact 1000mg/500mg Injection:
Administering this medication will be done by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Ekobact 1000mg/500mg Injection:
- Decreased white blood cell count (neutrophils)
- Decreased white blood cell count (lymphocytes)
- Decreased hemoglobin
- Decreased hematocrit level
- Low blood platelets
- Coagulation disorder
- Increased white blood cell count (eosinophils)
- Diarrhea
- Nausea
- Increased alanine aminotransferase
- Increased aspartate aminotransferase
- Increased alkaline phosphatase level in blood
- Vomiting
- Increased bilirubin in the blood
How to use Ekobact 1000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Ekobact 1000mg/500mg Injection works:
Cefoperazone and Sulbactam, combined as Ekobact 1000mg/500mg Injection, offer a dual-action approach to bacterial infection. Cefoperazone, a broad-spectrum antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to reproduce. The inclusion of Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby optimizing Cefoperazone's effectiveness.
SAFETY ADVICE
AlcoholUNSAFE
Ingestion of alcohol during treatment with Ekobact 1000mg/500mg Injection can result in adverse effects including facial redness, rapid pulse, vomiting, dehydration, chest discomfort, and hypotension (a disulfiram-like reaction).
PregnancySAFE IF PRESCRIBED
Pregnancy use of Ekobact 1000mg/500mg Injection is generally deemed safe. Preclinical trials in animals revealed minimal or no harm to offspring; however, clinical data in pregnant women are scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Ekobact 1000mg/500mg Injection is considered safe for breastfeeding mothers. Research in humans indicates negligible transfer of the medication into breast milk, posing no known risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Ekobact 1000mg/500mg Injection on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ekobact 1000mg/500mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ekobact 1000mg/500mg Injection to individuals with hepatic impairment. Seek medical advice.
What if you forget to take Ekobact 1000mg/500mg Injection :
Omitting a scheduled dose of Ekobact 1000mg/500mg Injection requires contacting your physician.
Facts to Know About Ekobact 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Infective Agents Inhibitors |
